Blood biopsy reveals unique, targetable genetic alterations in patients with rare cancer

(University of California - San Diego) Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news